News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US FDA Staff Says Genentech, Inc. (DNA)'s Avastin Brain Cancer Data Unclear


3/30/2009 8:07:38 AM

WASHINGTON, March 27 (Reuters) - It is difficult to tell how well brain cancer patients responded to Genentech Inc's cancer drug Avastin in early studies from the company, U.S. Food and Drug Administration staff said in documents released on Friday.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES